Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Sotera Health (SHC)

Sotera Health Q3 revenue rises 9.1% to $311 million; raises Adjusted EBITDA outlook

Positive Impact 4 of 5 earnings Written later

Sotera Health reported third-quarter 2025 net revenues up 9.1% to $311 million and net income of $48 million, or $0.17 per diluted share, compared with $17 million, or $0.06, a year earlier. The company raised its 2025 Adjusted EBITDA growth outlook to 6.75% to 7.75% and kept its net revenue growth outlook at 4.5% to 6.0%, on a constant currency basis.

Key points

  • Q3 2025 net income was $48 million, or $0.17 per diluted share, versus $17 million, or $0.06, in Q3 2024.
  • Q3 2025 Adjusted EBITDA rose 12.2% to $164 million; Adjusted EPS was $0.26, up from $0.17.
  • 2025 Adjusted EBITDA growth outlook raised to 6.75% to 7.75%, from 6.00% to 7.50%.
  • 2025 Adjusted EPS outlook raised to $0.81 to $0.86, from $0.75 to $0.82; net revenue outlook reaffirmed at 4.5% to 6.0%.

The filing

CompanySotera Health (SHC)
Form8-K, current report
Filed with the SECNov 4, 2025, 7:07 AM ET
Accession number0001822479-25-000050

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:00 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 04, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.